Septerna, Inc. (SEPN)
38.89
-0.24
(-0.61%)
USD |
NASDAQ |
Oct 01, 13:48
Septerna Gross Profit Margin (Quarterly) : 98.40% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 98.40% |
| March 31, 2026 | 98.41% |
| December 31, 2025 | 98.34% |
| September 30, 2025 | 98.14% |
| June 30, 2025 | -236.1% |
| March 31, 2025 | -81.28% |
| Date | Value |
|---|---|
| December 31, 2024 | -83.02% |
| September 30, 2024 | -106.8% |
| June 30, 2024 | 10.00% |
| March 31, 2024 | 0.32% |
| December 31, 2023 | -105.9% |
| September 30, 2023 | -606.1% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 88.57% |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 95.92% |
| Fulcrum Therapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -6.33% |
| Return on Assets | -4.39% |
| Return on Invested Capital | -5.97% |
| Profit Margin (Quarterly) | -48.73% |
| Operating Margin (Quarterly) | -62.95% |
| Return on Net Operating Assets | -60.45% |